Bilaketaren emaitzak - Wim Robberecht

Findu emaitzak
  1. 1
    AMPA Receptor Calcium Permeability, GluR2 Expression, and Selective Motoneuron Vulnerability

    AMPA Receptor Calcium Permeability, GluR2 Expression, and Selective Motoneuron Vulnerability nork Wim Vandenberghe, Wim Robberecht, James R. Brorson

    Argitaratua 2000
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  2. 2
    Modifying expression of EphA4 and its downstream targets improves functional recovery after stroke

    Modifying expression of EphA4 and its downstream targets improves functional recovery after stroke nork Robin Lemmens, Tom Jaspers, Wim Robberecht, Vincent Thijs

    Argitaratua 2013
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  3. 3
    The Role of Oligodendroglial Dysfunction in Amyotrophic Lateral Sclerosis

    The Role of Oligodendroglial Dysfunction in Amyotrophic Lateral Sclerosis nork Annelies Nonneman, Wim Robberecht, Ludo Van Den Bosch

    Argitaratua 2014
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  4. 4
    RNA toxicity in non‐coding repeat expansion disorders

    RNA toxicity in non‐coding repeat expansion disorders nork Bart Swinnen, Wim Robberecht, Ludo Van Den Bosch

    Argitaratua 2019
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  5. 5
    Modelling amyotrophic lateral sclerosis: progress and possibilities

    Modelling amyotrophic lateral sclerosis: progress and possibilities nork Philip Van Damme, Wim Robberecht, Ludo Van Den Bosch

    Argitaratua 2017
    Testu osoa Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  6. 6
    Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS)

    Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS) nork Lindsay Poppe, Laura Rué, Wim Robberecht, Ludo Van Den Bosch

    Argitaratua 2014
    Testu osoa
    Revisão
    Gogokoenen artean sartu
    Gorde:
  7. 7
    GluR2 Deficiency Accelerates Motor Neuron Degeneration in a Mouse Model of Amyotrophic Lateral Sclerosis

    GluR2 Deficiency Accelerates Motor Neuron Degeneration in a Mouse Model of Amyotrophic Lateral Sclerosis nork Philip Van Damme, Dries Braeken, Geert Callewaert, Wim Robberecht, Ludo Van Den Bosch

    Argitaratua 2005
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  8. 8
    GluR2-Dependent Properties of AMPA Receptors Determine the Selective Vulnerability of Motor Neurons to Excitotoxicity

    GluR2-Dependent Properties of AMPA Receptors Determine the Selective Vulnerability of Motor Neurons to Excitotoxicity nork Philip Van Damme, Ludo Van Den Bosch, E Van Houtte, Geert Callewaert, Wim Robberecht

    Argitaratua 2002
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  9. 9
    Influence of Arterial Input Function on Hypoperfusion Volumes Measured With Perfusion-Weighted Imaging

    Influence of Arterial Input Function on Hypoperfusion Volumes Measured With Perfusion-Weighted Imaging nork Vincent Thijs, Diederik M. Somford, Roland Bammer, Wim Robberecht, Michael E. Moseley, Gregory W. Albers

    Argitaratua 2003
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  10. 10
    Prospective Validation of <sup>18</sup>F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis

    Prospective Validation of <sup>18</sup>F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis nork Donatienne Van Weehaeghe, Jenny Ceccarini, Aline Delva, Wim Robberecht, Philip Van Damme, Koen Van Laere

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  11. 11
    Upregulation of HSP27 in a Transgenic Model of ALS

    Upregulation of HSP27 in a Transgenic Model of ALS nork V. Vleminckx, Philip Van Damme, Karolien Goffin, Hans Delye, Ludo Van Den Bosch, Wim Robberecht

    Argitaratua 2002
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  12. 12
    Noninvasive Ventilation Improves Sleep in Amyotrophic Lateral Sclerosis: A Prospective Polysomnographic Study

    Noninvasive Ventilation Improves Sleep in Amyotrophic Lateral Sclerosis: A Prospective Polysomnographic Study nork Bart Vrijsen, Bertien Buyse, Catharina Belge, Wim Robberecht, Philip Van Damme, Marc Decramer, Dries Testelmans

    Argitaratua 2015
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  13. 13
    Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T)mice

    Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T)mice nork Sarah Herdewyn, Carla Cirillo, Ludo Van Den Bosch, Wim Robberecht, Pieter Vanden Berghe, Philip Van Damme

    Argitaratua 2014
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  14. 14
    Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot–Marie–Tooth Disease

    Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot–Marie–Tooth Disease nork Veronick Benoy, Pieter Vanden Berghe, Matthew Jarpe, Philip Van Damme, Wim Robberecht, Ludo Van Den Bosch

    Argitaratua 2016
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  15. 15
    Value of<sup>18</sup>Fluorodeoxyglucose–Positron-Emission Tomography in Amyotrophic Lateral Sclerosis

    Value of<sup>18</sup>Fluorodeoxyglucose–Positron-Emission Tomography in Amyotrophic Lateral Sclerosis nork Koen Van Laere, Annelies Vanhee, Jolien Verschueren, Liesbeth De Coster, An Driesen, Patrick Dupont, Wim Robberecht, Philip Van Damme

    Argitaratua 2014
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  16. 16
    Progranulin is Neurotrophic In Vivo and Protects against a Mutant TDP-43 Induced Axonopathy

    Progranulin is Neurotrophic In Vivo and Protects against a Mutant TDP-43 Induced Axonopathy nork Angela S. Laird, Annelies Van Hoecke, Louis De Muynck, Mieke Timmers, Ludo Van Den Bosch, Philip Van Damme, Wim Robberecht

    Argitaratua 2010
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  17. 17
    FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins

    FUS-induced neurotoxicity in Drosophila is prevented by downregulating nucleocytoplasmic transport proteins nork Jolien Steyaert, Wendy Scheveneels, J. Vanneste, Philip Van Damme, Wim Robberecht, Patrick Callaerts, Elke Bogaert, Ludo Van Den Bosch

    Argitaratua 2018
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  18. 18
    Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study

    Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study nork Greet Hermans, Maarten Schrooten, Philip Van Damme, N. Berends, Bernard Bouckaert, Wouter De Vooght, Wim Robberecht, Greet Van den Berghe

    Argitaratua 2009
    Testu osoa Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  19. 19
    Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS

    Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS nork Ines Taes, Mieke Timmers, Nicole Hersmus, André Bento‐Abreu, Ludo Van Den Bosch, Philip Van Damme, Johan Auwerx, Wim Robberecht

    Argitaratua 2013
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:
  20. 20
    Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: Revisited

    Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: Revisited nork Caroline Sage, Wim Van Hecke, Ronald Peeters, Jan Sijbers, Wim Robberecht, Paul M. Parizel, Guy Marchal, Alexander Leemans, Stefan Sunaert

    Argitaratua 2009
    Testu osoa
    Artigo
    Gogokoenen artean sartu
    Gorde:

Bilaketa egiteko lanabesak: